Get the Stockscreener App
25.59
4.41%
1.08
Pre-market:
25.59
Astrana Health Inc stock is traded at $25.59, with a volume of 713.68K.
It is up +4.41% in the last 24 hours and up +16.16% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
See More
Previous Close:
$24.51
Open:
$25.3
24h Volume:
713.68K
Relative Volume:
1.28
Market Cap:
$1.28B
Revenue:
$2.42B
Net Income/Loss:
$27.64M
P/E Ratio:
50.18
EPS:
0.51
Net Cash Flow:
$121.24M
1W Performance:
+28.27%
1M Performance:
+16.16%
6M Performance:
-16.97%
1Y Performance:
-4.44%
1-Day Range:
$24.50
$26.63
1-Week Range:
$19.84
$26.63
52-Week Range:
$18.08
$34.80
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, FMS, UHS, ENSG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
25.59 | 1.23B | 2.42B | 27.64M | 121.24M | 0.51 |
|
HCA
Hca Healthcare Inc
|
544.41 | 121.16B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
244.80 | 21.12B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.03 | 13.05B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
202.31 | 12.51B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
212.05 | 12.39B | 4.11B | 239.98M | 193.10M | 4.12 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | Needham | Buy |
| Apr-01-25 | Initiated | Barclays | Equal Weight |
| Oct-14-24 | Initiated | TD Cowen | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-11-24 | Upgrade | Truist | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Feb-26-24 | Initiated | Jefferies | Buy |
| Feb-22-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-24 | Initiated | Stifel | Buy |
| Dec-22-23 | Initiated | Truist | Hold |
| Oct-17-23 | Initiated | BTIG Research | Buy |
| Apr-12-23 | Initiated | BofA Securities | Neutral |
| Dec-19-22 | Initiated | Lake Street | Buy |
| Sep-21-22 | Initiated | William Blair | Outperform |
| Jan-11-22 | Resumed | Colliers Securities | Buy |
| Aug-12-21 | Initiated | Barclays | Equal Weight |
View All
Astrana Health Inc Stock (ASTH) Latest News
Royce & Associates LP Reduces Stock Holdings in Astrana Health, Inc. $ASTH - MarketBeat
Is Astrana Health (ASTH) Still Attractive After The Recent 28% Weekly Price Jump - simplywall.st
Vanguard Group Inc. Sells 112,308 Shares of Astrana Health, Inc. $ASTH - MarketBeat
Astrana Health : Investor Presentation – March 2026 - marketscreener.com
Astrana Health Updates Investor Presentation on Value-Based Strategy - TipRanks
Astrana Health updates corporate presentation, reiterates FY2026 revenue $3.8–4.1B and Adj. EBITDA $250–280M guidance - TradingView
Astrana Health (NASDAQ: ASTH) issues 2026 growth guidance and flags control weakness - Stock Titan
Cigna CEO Cordani To Retire, Successor Named At Bloomfield-Based Health Care Giant - AOL.com
Astrana Health (ASTH +29%): Massive EPS Beat & Strong 2026 Guidance Ignites Rally - Trefis
Doctor-focused Astrana Health lines up five investor talks in March - Stock Titan
ASTH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Astrana Health Posts Upbeat Q4 Earnings, Joins AeroVironment, Kratos Defense & Security Solutions And Other Big Stocks Moving Higher On Monday - Sahm
Astrana Health Inc. (ASTH) - DirectorsTalk Interviews
Astrana Health Juggles Profit Turnaround Buybacks And 10 K Delay - Yahoo Finance
Needham raises Astrana Health stock price target to $30 on outlook - Investing.com UK
Astrana Health raises share repurchase authorization to $100M - TipRanks
Astrana Health reports Q4 adjusted EPS 54c, consensus 33c - TipRanks
Astrana Health Earnings Call Balances Records and Risks - TipRanks
Why Astrana Health (ASTH) Stock Is Up Today - Finviz
Top Midday Gainers - marketscreener.com
Astrana Health, Inc. Provides Revenue Guidance for the Three Months Ending March 31, 2026 and for Year Ending December 31, 2026 - marketscreener.com
Astrana Health, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Astrana Health Q4 2025 Earnings: Revenue Exceeds Expectations, 2026 GuidanceNews and Statistics - IndexBox
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Astrana Health Q4 Earnings Call Highlights - Yahoo Finance
Astrana Health (NASDAQ:ASTH) Shares Gap Up After Strong Earnings - MarketBeat
Astrana Health (ASTH) Q4 2025 Earnings Transcript - AOL.com
Earnings call transcript: Astrana Health Q4 2025 beats EPS forecast, stock surges - Investing.com
Astrana Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Astrana Health Delays Filing of Annual Report - TipRanks
Astrana Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ASTH) 2026-03-02 - Seeking Alpha
Astrana Health (NASDAQ: ASTH) delays 2025 Form 10-K; expects material weakness disclosure - Stock Titan
Astrana Health, Inc. (ASTH) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Astrana Health (NASDAQ:ASTH) Beats Q4 CY2025 Sales Expectations - Finviz
Astrana Health Reports Record 2025 Results, Expands Buyback - TipRanks
Astrana Health Q4 Adjusted Earnings, Revenue Rise; Q1, 2026 Revenue Outlook Issued - marketscreener.com
(ASTH) Astrana Health Expects 2026 Total Revenue Range $3.80B$4.10B, vs. FactSet Est of $3.96B - marketscreener.com
Astrana Health (NASDAQ:ASTH) Issues Quarterly Earnings Results - MarketBeat
ASTRANA HEALTH ($ASTH) Releases Q4 2025 Earnings - Quiver Quantitative
(ASTH) Astrana Health, Inc. Expects Q1 Revenue Range $900.0M$1.00B - marketscreener.com
Earnings Flash (ASTH) Astrana Health, Inc. Reports Q4 Revenue $950.5M, vs. FactSet Est of $930.4M - marketscreener.com
Astrana Health stock rises above 3% on earnings beat and strong guidance - Investing.com UK
Astrana Health (NASDAQ: ASTH) grows 2025 revenue 56% but flags control weakness - Stock Titan
Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results - PR Newswire
Insights into Astrana Health Q4 Earnings - Sahm
A Look At Astrana Health’s Valuation As Upcoming Earnings Test Optimistic Growth Expectations - simplywall.st
Will Anticipated Strong Earnings and Guidance Shift Astrana Health's (ASTH) Value‑Based Care Narrative? - Sahm
Earnings Outlook For Astrana Health - Benzinga
Astrana Health set to report earnings after profit stumble By Investing.com - Investing.com Australia
Bank Watch: Is MLYS forming higher highs and higher lowsMarket Trend Report & Growth Focused Entry Point Reports - baoquankhu1.vn
Astrana Health, Inc. (NASDAQ:ASTH) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Astrana Health Inc Stock (ASTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
| Kitayama Mitchell W | Director |
Sep 15 '25 |
Option Exercise |
18.20 |
8,000 |
145,600 |
29,060 |
| Schmidt David | Director |
Sep 02 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
35,763 |
| Chiang John | Director |
Aug 13 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
43,132 |
1.54%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):